IMXI
International Money Express, Inc.
IMXI trails on the overall score without a compensating advantage in the available component scores.
MSFT
Microsoft Corporation
MSFT has the edge over IMXI overall, supported by stronger modeled upside and stronger fundamentals.
IMXI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
IMXI's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
IMXI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.4x | $6.39 | — |
| Cheap | 11x | $6.63 | +3.8% |
| Current | 11x | $6.39 | — |
| Fair | 15x | $8.92 | +40% |
| Expensive | 19x | $11.18 | +75% |
Historical ranges are pointers, not guarantees.
IMXI's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 7.4x.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over IMXI in the historical PE scenario, which offers more potential upside but is not a forecast.
IMXI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect IMXI's earnings and revenue to decline, with profitability weakening.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
MSFT has the edge over IMXI on the outlook, with more favorable earnings and revenue expectations.
IMXI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | +46% |
| Q3 2026 | $0.59 | -54% |
| Q2 2026 | $0.62 | -62% |
| Q1 2026 | $0.85 | -50% |
| Q4 2025 | $1.08 | -40% |
| Q3 2025 | $1.28 | -28% |
| Q2 2025 | $1.64 | -1.8% |
| Q1 2025 | $1.69 | +1.2% |
| Q4 2024 | $1.79 | +9.8% |
IMXI's earnings per share have fallen from their peak: $0.59 over the past year, against $1.79 in late 2024.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over IMXI on earnings, with more consistent year-over-year improvement.
IMXI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $126.4M | -18% |
| Q2 2026 | $131.2M | -19% |
| Q1 2026 | $122M | -15% |
| Q4 2025 | $147.4M | -11% |
| Q3 2025 | $154.9M | -9.9% |
| Q2 2025 | $161.1M | -6.1% |
| Q1 2025 | $144.3M | -4.1% |
| Q4 2024 | $164.8M | -4.1% |
IMXI's revenue has slid since its 2023 peak: $126M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +0.4 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 3% | -6.7 points |
| Q4 2025 | 7.8% | -7.1 points |
| Q3 2025 | 6.8% | -9.4 points |
| Q2 2025 | 12% | -1.3 points |
| Q1 2025 | 9.8% | -3.3 points |
| Q4 2024 | 15% | -1.1 points |
IMXI's operating margin was 7.2% last quarter, about level with the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over IMXI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over IMXI on profitability, with a higher operating margin.
IMXI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | +$38.8M |
| Q2 2026 | $107.2M | +203% |
| Q1 2026 | -$42.9M | -219% |
| Q4 2025 | -$20M | -$11.2M |
| Q3 2025 | -$35.5M | -252% |
| Q2 2025 | $35.3M | +$61.6M |
| Q1 2025 | $36M | +3.6% |
| Q4 2024 | -$8.8M | -116% |
IMXI has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
IMXI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +49.2K shares |
| 1 year | +2.8% | +841K shares |
| 3 years | -15% | -5.4M shares |
| 5 years | -22% | -8.7M shares |
| Available history | -20% | -7.6M shares |
IMXI has 31M diluted shares, up 2.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $11.4M |
| Q1 2025 | $5M |
| Q4 2024 | $20.2M |
IMXI hasn't bought back shares in the past year.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over IMXI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
IMXI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 0.2x | Very low |
IMXI has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
IMXI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.9 | Oversold |
| Stochastic | 7.3 | Oversold |
IMXI's weekly RSI is 22 (oversold) and its Stochastic is 7 (oversold).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
IMXI PE vs Technology Sector
| Metric | IMXI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 14 | 35 | 21 pts below |
IMXI has the edge over MSFT on valuation relative to its sector.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
IMXI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.74 | 34% below |
| 20 week MA | $12.1 | 47% below |
| 50 week MA | $14.1 | 55% below |
| 100 week MA | $14.1 | 55% below |
| 200 week MA | $17.6 | 64% below |
IMXI is in a downtrend: it's below all five of its weekly moving averages, and 64% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over IMXI on trend strength, trading above more of its moving averages.
IMXI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.0 | $15.9 | +32% |
| 2021 | $15.9 | $15.8 | -0.6% |
| 2022 | $15.8 | $22.5 | +43% |
| 2023 | $22.5 | $22.1 | -1.6% |
| 2024 | $22.1 | $20.6 | -6.6% |
| 2025 | $20.6 | $15.4 | -25% |
| 2026 YTD | $15.4 | $6.39 | -59% |
IMXI has finished three years in a row lower, and it's down 59% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over IMXI on returns for 2026, with the stronger performance.